Celldex Therapeutics
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $22 | $15 | $75 | $0 |
Gross Profit | 22 | -839 | 75 | -62,931 |
EBITDA | -72,601 | -77,831 | -80,544 | -66,220 |
EBIT | -73,503 | -78,685 | -81,360 | -67,044 |
Net Income | -73,503 | -78,685 | -81,360 | -67,044 |
Net Change In Cash | 22 | 15 | 75 | 0 |
Free Cash Flow | -60,589 | -67,227 | -64,933 | -49,068 |
Cash | 47,454 | 35,729 | 28,871 | 36,037 |
Basic Shares | 77,840 | 66,566 | 66,500 | 66,420 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $1,500 | $7,020 | $6,883 | $2,357 |
Gross Profit | 1,500 | -156,530 | -111,128 | -79,901 |
EBITDA | -255,420 | -154,686 | -139,034 | -104,200 |
EBIT | -258,800 | -157,863 | -142,042 | -107,096 |
Net Income | -258,800 | -157,863 | -141,429 | -112,325 |
Net Change In Cash | 1,500 | 7,020 | 6,883 | 2,357 |
Free Cash Flow | -213,659 | -159,697 | -109,109 | -105,560 |
Cash | 28,871 | 28,356 | 34,814 | 29,429 |
Basic Shares | 66,500 | 64,395 | 48,449 | 46,888 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.94 |
2026-03-31 | -$1.18 |
2025-12-31 | -$1.22 |
2025-09-30 | -$1.01 |